Background Human genetics research lacks diversity; over 80% of genome‐wide association
studies have been conducted on individuals of European ancestry. In addition to limiting …

Proteomics and metabolomics are two emerging fields that hold promise to shine light on
the molecular mechanisms causing neurodegenerative diseases. Research in this area may …

Introduction Subjective cognitive decline (SCD) may be an early symptom of Alzheimer's
disease. We aimed to estimate the prevalence of SCD in Brazil and its association with …

Background Risk factors for dementia have distinct frequency and impact in relation to race.
Our aim was to identify differences in modifiable risk factors of dementia related to races and …

Introduction Alzheimer's disease consensus recommends biomarker dichotomization, a
practice with well‐described clinical strengths and methodological limitations. Although …

Background Changes in soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are
detectable at early preclinical stages of Alzheimer’s disease (AD). However, whether Aβ levels …

Alzheimer's disease (AD) treatment is freely available in the Brazilian public health system.
However, the prescription pattern and its associated factors have been poorly studied in our …

Human genetics research lacks diversity; over 80% of genome-wide association studies (GWAS)
have been conducted on individuals of European ancestry. In addition to limiting …

This paper presents solutions to increase efficiency and reduce response times at an
emergency call center in the southernmost state of Brazil, Rio Grande do Sul. Utilizing macro-…

Understanding whether vascular risk factors (VRFs) synergistically potentiate Alzheimer's
disease (AD) progression is important in the context of emerging treatments for preclinical AD. …